Catalyst Wire Dossier Catalyst Wire Dossier

Nuzyra

Omadacycline · Paratek Pharmaceuticals
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Nuzyra, covering 2018-10-02 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection [Phase 2]

See pricing